Oligoamine analogues in combination with 2-difluoromethylornithine synergistically induce re-expression of aberrantly silenced tumour-suppressor genes.
about
Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment?Polyamines and cancer: implications for chemotherapy and chemopreventionEpigenetic therapy: use of agents targeting deacetylation and methylation in cancer management.KDM1A promotes tumor cell invasion by silencing TIMP3 in non-small cell lung cancer cells.Brain-specific epigenetic markers of schizophrenia.Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration.Chromatin remodeling by polyamines and polyamine analogs.Polyamines metabolism and breast cancer: state of the art and perspectives.Structure-activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architecturesSynthesis and evaluation of 3-amino/guanidine substituted phenyl oxazoles as a novel class of LSD1 inhibitors with anti-proliferative properties.A selective phenelzine analogue inhibitor of histone demethylase LSD1.Epigenetic control and cancer: the potential of histone demethylases as therapeutic targets.Synthesis and Deployment of an Elusive Fluorovinyl Cation Equivalent: Access to Quaternary α-(1'-Fluoro)vinyl Amino Acids as Potential PLP Enzyme Inactivators.Polyamines and Cancer.Histone Demethylase LSD1 Inhibitors Prevent Cell Growth by Regulating Gene Expression in Esophageal Squamous Cell Carcinoma Cells.Curcumin mediates polyamine metabolism and sensitizes gastrointestinal cancer cells to antitumor polyamine-targeted therapies
P2860
Q26775413-F97584C9-2BB6-4727-A6CB-5B459A2B19F6Q26864516-A513AD7A-8451-4A0A-A0DE-C5B9ACFE5FB9Q36738463-CCCAF88F-8BDF-40C1-8A4C-25331E06DE7BQ37317452-BE649060-7943-44A8-AB2B-3AAF5946400BQ37347673-BE6BBD4F-456A-48AC-9006-A56FFEB58221Q37436085-6F757716-E7C3-468D-8022-C7FE7DB93BE9Q38120212-58D344C5-A3AD-4D14-BD18-4B2AFEAC33CBQ38257840-2C937EB9-318F-4CEC-9C5F-2D4FDA11E16AQ38905191-BD7076AA-429E-4277-B6A0-61E125EEC655Q39168354-8E003292-72F4-48C7-9423-A8AE78200AFDQ41514691-90ED028B-0465-48AA-91F6-26B8808E9249Q42922825-7C025699-8811-4C3F-9513-62DD36417184Q47804072-9D6B5510-EBE5-436A-8947-9964BBC29D86Q50100821-FAB2FA7E-050B-4447-8AD4-7D0DEEEEFABBQ53571645-A332B013-C105-493E-8AEA-5118D9AEC0C0Q58715258-61B5DF23-FD43-4EB5-B652-C2FFDD66A0E3
P2860
Oligoamine analogues in combination with 2-difluoromethylornithine synergistically induce re-expression of aberrantly silenced tumour-suppressor genes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Oligoamine analogues in combin ...... enced tumour-suppressor genes.
@ast
Oligoamine analogues in combin ...... enced tumour-suppressor genes.
@en
type
label
Oligoamine analogues in combin ...... enced tumour-suppressor genes.
@ast
Oligoamine analogues in combin ...... enced tumour-suppressor genes.
@en
prefLabel
Oligoamine analogues in combin ...... enced tumour-suppressor genes.
@ast
Oligoamine analogues in combin ...... enced tumour-suppressor genes.
@en
P2093
P2860
P356
P1433
P1476
Oligoamine analogues in combin ...... enced tumour-suppressor genes.
@en
P2093
Laurence J Marton
Nora Steinbergs
Robert A Casero
Tracy Murray-Stewart
P2860
P304
P356
10.1042/BJ20111271
P407
P577
2012-03-01T00:00:00Z